• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经鼻内镜颅底入路切除伴有蛛网膜下腔侵犯的巨大垂体腺瘤:避免术后卒中的“第二层”策略。

Endoscopic Endonasal Transtubercular Approach for Resection of Giant Pituitary Adenomas With Subarachnoid Extension: The "Second Floor" Strategy to Avoid Postoperative Apoplexy.

机构信息

Department of Neurological Surgery Neck Surgery, The Ohio State University, Wexner Medical Center, Columbus, Ohio, USA.

Department of Neurological Surgery Neck Surgery, The Ohio State University, Wexner Medical Center, Columbus, Ohio, USA; Department of Otolaryngology Head and Neck Surgery, The Ohio State University, Wexner Medical Center, Columbus, Ohio, USA.

出版信息

World Neurosurg. 2021 Sep;153:e464-e472. doi: 10.1016/j.wneu.2021.06.142. Epub 2021 Jul 6.

DOI:10.1016/j.wneu.2021.06.142
PMID:34242829
Abstract

BACKGROUND

Giant pituitary adenomas (GPAs) with subarachnoid extension can be challenging to achieve a gross total resection through a single endonasal or transcranial approach, and any residual tumor is at risk for postoperative apoplexy. Intraoperative venous congestion of the suprasellar tumor can occur following resection of the sellar tumor, limiting tumor descent, and leading to suprasellar residual. We propose a technique for resecting the suprasellar component first, which we call the "second floor" strategy (SFS) for GPA.

METHODS

A retrospective review of cases from 2010-2020 identified 586 endoscopic endonasal approaches (EEAs) for pituitary adenoma resection. We report the rate of postoperative apoplexy and describe the SFS technique used in 2 cases.

RESULTS

Of 586 cases, 2 developed symptomatic postoperative apoplexy (0.3%), and a third transferred to our care after undergoing postoperative apoplexy. All 3 cases had subarachnoid extension of a pituitary adenoma, underwent EEA, and had residual suprasellar tumor. All 3 had permanent morbidity due to the postoperative apoplexy including blindness, stroke, or death, despite undergoing reoperation. The SFS was used for reoperation on 1 of these patients and as a primary strategy in a fourth patient who presented with a GPA with subarachnoid extension. We describe the SFS technique and demonstrate it with a 2-dimensional operative video.

CONCLUSIONS

Postoperative apoplexy of residual adenoma is a rare but serious complication after GPA resection. The proposed SFS allows early access to the suprasellar tumor and may improve the ability to safely achieve a gross total resection without need for additional procedures.

摘要

背景

具有蛛网膜下腔延伸的巨大垂体腺瘤(GPAs)通过单一经鼻或经颅入路难以实现全切,任何残留肿瘤都有术后卒中的风险。鞍上肿瘤切除后可能会出现颅内静脉淤血,限制肿瘤下降,导致鞍上残留。我们提出了一种先切除鞍上部分的技术,我们称之为 GPA 的“第二层”策略(SFS)。

方法

回顾 2010 年至 2020 年的病例,确定了 586 例内镜经鼻入路(EEA)用于垂体腺瘤切除术。我们报告术后卒中的发生率,并描述了在 2 例中使用的 SFS 技术。

结果

在 586 例中,有 2 例发生症状性术后卒中(0.3%),其中 1 例在术后卒中后转至我们处治疗。所有 3 例均有蛛网膜下腔延伸的垂体腺瘤,行 EEA 治疗,且有残留的鞍上肿瘤。所有 3 例均因术后卒中导致永久性残疾,包括失明、中风或死亡,尽管进行了再次手术。其中 1 例患者采用 SFS 进行再次手术,另 1 例伴有蛛网膜下腔延伸的 GPA 患者采用 SFS 作为主要策略。我们描述了 SFS 技术,并通过二维手术视频进行了演示。

结论

术后残余腺瘤卒中是 GPA 切除后一种罕见但严重的并发症。所提出的 SFS 可早期接触鞍上肿瘤,并可能改善安全实现全切的能力,而无需额外的手术。

相似文献

1
Endoscopic Endonasal Transtubercular Approach for Resection of Giant Pituitary Adenomas With Subarachnoid Extension: The "Second Floor" Strategy to Avoid Postoperative Apoplexy.经鼻内镜颅底入路切除伴有蛛网膜下腔侵犯的巨大垂体腺瘤:避免术后卒中的“第二层”策略。
World Neurosurg. 2021 Sep;153:e464-e472. doi: 10.1016/j.wneu.2021.06.142. Epub 2021 Jul 6.
2
Pituitary Apoplexy Case Series: Outcomes After Endoscopic Endonasal Transsphenoidal Surgery at a Single Tertiary Center.垂体卒中病例系列:单一三级中心经鼻内镜经蝶窦手术的结果。
World Neurosurg. 2020 May;137:e366-e372. doi: 10.1016/j.wneu.2020.01.204. Epub 2020 Feb 4.
3
Surgical anatomy and nuances of the extended endoscopic endonasal transtuberculum sellae approach: pearls and pitfalls for complications avoidance.经蝶鞍延伸内镜经鼻蝶窦入路的手术解剖和细微之处:避免并发症的要点和陷阱。
Acta Neurochir (Wien). 2021 Feb;163(2):399-405. doi: 10.1007/s00701-020-04625-x. Epub 2020 Nov 6.
4
Endoscopic Endonasal Approach to Multilobular Giant Pituitary Adenoma with Cavernous Sinus Invasion and Petroclival Extension.内镜经鼻入路切除海绵窦侵袭性和岩斜区延伸的多叶巨大垂体腺瘤
World Neurosurg. 2021 Mar;147:128-129. doi: 10.1016/j.wneu.2020.11.055. Epub 2020 Nov 19.
5
Endoscopic endonasal surgery for giant pituitary adenomas: advantages and limitations.内镜经鼻蝶入路手术治疗巨大垂体腺瘤:优势与局限性。
J Neurosurg. 2013 Mar;118(3):621-31. doi: 10.3171/2012.11.JNS121190. Epub 2013 Jan 4.
6
Safety and Effectiveness of the Direct Endoscopic Endonasal Approach for Primary Sellar Pathology: A Contemporary Case Series of More Than 400 Patients.直接经鼻内镜下治疗原发性鞍区病变的安全性和有效性:400 多例患者的当代病例系列。
World Neurosurg. 2021 Apr;148:e536-e546. doi: 10.1016/j.wneu.2021.01.018. Epub 2021 Jan 14.
7
Endoscopic endonasal transsphenoidal approach to large and giant pituitary adenomas: institutional experience and predictors of extent of resection.经鼻内镜蝶窦入路切除大型和巨大型垂体腺瘤:机构经验和影响切除程度的预测因素。
J Neurosurg. 2014 Jul;121(1):75-83. doi: 10.3171/2014.3.JNS131679. Epub 2014 May 2.
8
Endoscopic Endonasal Surgery for Treatment of Pituitary Apoplexy: 16 Years of Experience in a Specialized Pituitary Center.经鼻内镜手术治疗垂体卒中:在专业垂体中心的16年经验
World Neurosurg. 2017 Dec;108:137-142. doi: 10.1016/j.wneu.2017.08.131. Epub 2017 Sep 1.
9
Efficacy and Complications of Endoscopic Skull Base Surgery for Giant Pituitary Adenomas.内镜下经颅底手术治疗巨大垂体腺瘤的疗效与并发症
World Neurosurg. 2017 Mar;99:533-542. doi: 10.1016/j.wneu.2016.12.068. Epub 2016 Dec 23.
10
Surgical outcome of the endoscopic endonasal approach for non-functioning giant pituitary adenoma.内镜经鼻入路治疗无功能巨大垂体腺瘤的手术效果。
J Clin Neurosci. 2011 Jan;18(1):71-5. doi: 10.1016/j.jocn.2010.04.049. Epub 2010 Sep 20.

引用本文的文献

1
Beyond the sella: Expanded endoscopic endonasal approaches for pituitary tumors.蝶鞍之外:垂体瘤的扩大经鼻内镜入路
Neurooncol Adv. 2025 Jan 2;7(Suppl 1):i29-i39. doi: 10.1093/noajnl/vdae086. eCollection 2025 Jul.
2
Pituitary Apoplexy: a re-appraisal of risk factors and best management strategies in the COVID-19 era.垂体卒中:对COVID-19时代风险因素及最佳管理策略的重新评估
Pituitary. 2024 Dec;27(6):898-908. doi: 10.1007/s11102-024-01420-0. Epub 2024 Aug 5.